INTERNATIONAL PATENT: COGNIVUE, INC. FILES APPLICATION FOR "COGNITIVE SCREENING TEST FOR DETECTING PRECLINICAL ALZHEIMER'S DISEASE"

GENEVA, April 21 -- COGNIVUE, INC. (7911 Rae BlvdVictor, NY 14564) filed a patent application (PCT/US2024/051050) for "COGNITIVE SCREENING TEST FOR DETECTING PRECLINICAL ALZHEIMER'S DISEASE" on Oct 11, 2024. With publication no. WO/2025/081044, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GALVIN, James, E. (7911 Rae BlvdVictor, NY 14564)

Abstract: The Cognivue Test subtest scores may detect Preclinical Alzheimer's Disease (AD). This effect appears to be explained by: Adaptive Motor Response, Visual Salience, Shape D...